Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin Monotherapy vs Combination with Fosfomycin for CRAB Infections
NCT06570850Phase 4Recruiting
- Sponsor
- Chiang Mai University
- Start
- Apr 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fosfomycin in Acinetobacter baumannii infection (2 arms), sponsored by Chiang Mai University. Primary endpoint: Clinical response after completion of therapy. Started Apr 2023; status: recruiting.
02
Drugs
fosfomycin
03
Conditions
Acinetobacter baumannii infection
Beyond the preview
Go deeper on NCT06570850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06570850.